| P2093 | author name string | Huang CY | |
| | Lin SJ | |
| | Lin CP | |
| | Chen JW | |
| | Wu TC | |
| | Leu HB | |
| | Lin WT | |
| P2860 | cites work | The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 |
| | Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 |
| | Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels | Q29620696 |
| | Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits | Q31956644 |
| | Current perspectives on statins | Q33818381 |
| | Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels | Q33942737 |
| | High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention | Q35209311 |
| | Matrix metalloproteinases A review of their structure and role in acute coronary syndrome | Q35557333 |
| | Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture | Q35993294 |
| | Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease | Q40393362 |
| | Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein. | Q40475487 |
| | Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3. | Q40678114 |
| | Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II diet | Q43654962 |
| | Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events | Q43656468 |
| | Withdrawal of statins increases event rates in patients with acute coronary syndromes | Q43933090 |
| | Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice | Q44079684 |
| | Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease | Q44378566 |
| | Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages | Q44381124 |
| | Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells | Q44559213 |
| | Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins | Q45004040 |
| | Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia | Q45086055 |
| | C-reactive protein levels and outcomes after statin therapy | Q45213511 |
| | Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. | Q52541795 |
| P433 | issue | 2 | |
| P921 | main subject | simvastatin | Q670131 |
| | hypercholesterolemia | Q762713 |
| P304 | page(s) | 76-84 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
| P1476 | title | Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients | |
| P478 | volume | 36 | |